OVID

Ovid Therapeutics Inc. is a leading biopharmaceutical company based in New York, specializing in the development of transformative therapies for neurological disorders, a field marked by substantial unmet medical needs. The company is particularly focused on conditions such as epilepsy and employs its extensive expertise in neurology to innovate and enhance treatment options aimed at improving patient outcomes. With a strong pipeline of candidates, Ovid is well-positioned to make significant advancements in the biopharmaceutical sector, committed to elevating the quality of life for patients and their families through its cutting-edge therapies.